Induction treatment is often required before a full MDM ratifies details for the ongoing management plan. All CAYA will be inpatients when treatment starts, allowing their initial multidisciplinary management to be performed on the ward.

All CAYA acute leukaemia should be discussed as soon as possible after diagnosis at an appropriate MDM, with further discussions at the time of response assessment or final risk stratification.

All CAYA acute leukaemia should also be discussed at suitable MDMs that will include psychosocial and supportive care assessment.

Results of all relevant tests and access to images should be available for the MDM. Information about the patient’s concerns, preferences and social and cultural circumstances should also be available.